In these models, genetic inactivation of Usp9x (either by insertional mutagenesis or Pdx1-Cre mediated deletion) was found to enhance oncogenic KrasG12D in accelerating tumourogenesis and cancer progression [95]. This evidence concerns the gene USP9X and cancer.